Nature Biotechnology is a peer reviewed scientific journal published monthly by the Nature Publishing Group. The chief editor is Andrew Marshall who is part of an in-house team of editors.

It encompasses a wide range of applications, including genetic engineering, medical biotechnology, agricultural biotechnology, and industrial biotechnology. This eBook explores how biotechnology ...

Presentation of in vitro studies of RM-0256, a novel anti-PD-L1 antibody conjugated to IR700, which comprises a dual mode of photoimmunotherapy: depletion of PD-L1 expressing tumor cells and depletion ...

Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment ...

KAIMRC successfully hosted its 12 th annual global conference, dedicated this year to medical biotechnology, bioinformatics and biotherapeutics. Running from 14-16 th of September, the Riyadh ...

Learn more about whether ACADIA Pharmaceuticals Inc or Centessa Pharmaceuticals PLC - ADR is a better investment based on ...

Collecting and storing comprehensive data on human biospecimens is essential for generating high-quality, reproducible ...

The program is also ideal for biotechnology, pharmaceutical and medical device companies, who want to bring their products to the U.S. marketplace, as the certificate program covers current federal ...

The Fed plans to initiate rate cuts for the first time in over four years and investors do not know what to expect of the ...

Sophie Schweinitzer, MSc, is a PhD student at the Vienna University of Technology in the Cell Chip Group, which is focused on ...

A San Jose-based biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut ...

Learn more about whether Arcellx Inc or Centessa Pharmaceuticals PLC - ADR is a better investment based on AAII's A+ Investor ...